Currently out of the existing stock ratings of Craig Hettenbach, 142 are a BUY (39.01%), 52 are a SELL (14.29%), 170 are a HOLD (46.7%).

Craig Hettenbach

Work Performance Price Targets & Ratings Chart

Analyst Craig Hettenbach, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 70.7% that have a potential upside of 21.15% achieved within 214 days.

Craig Hettenbach’s has documented 646 price targets and ratings displayed on 32 stocks. The coverage is on Technology, Healthcare, Consumer Defensive, Consumer Cyclical sectors.

Most recent stock forecast was given on VEEV, Veeva Systems at 04-Mar-2026.

Wall Street Analyst Craig Hettenbach

Analyst best performing recommendations are on WOLF (WOLFSPEED).
The best stock recommendation documented was for ON (ON SEMICONDUCTOR) at 3/18/2020. The price target of $13 was fulfilled within 6 days with a profit of $4.55 (53.85%) receiving and performance score of 89.74.

Average potential price target upside

ADI Analog Devices APH Amphenol AVGO Broadcom CREE Cree CY Cypress Semiconductor MCHP Microchip Technology NXPI NXP Semiconductors NV ON ON Semiconductor PI Impinj QRVO Qorvo ST Sensata Technologies Holding NV SWKS Skyworks Solutions TEL TE Connectivity Ltd TXN Texas Instruments DH Definitive Healthcare Corp WOLF Wolfspeed SLAB Silicon Laboratories SHCR Sharecare RCM R1 RCM MODN Model N DOCS Doximity AMWL American Well Corp VEEV Veeva Systems GDRX Goodrx Holdings  HCA HCA Holdings ARDT Ardent Health Partners HIMS Hims Hers Health THC Tenet Healthcare UHS Universal Health Services PII Polaris Industries SHC Sotera Health Co SYNA Synaptics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Jan-2016

$498

$111.09 (28.71%)

$405

17 days ago
(24-Jun-2026)

39/40 (97.5%)

$84.84 (20.53%)

487

Buy Since 21-Sep-2021

$450

$63.09 (16.31%)

$400

1 months 15 days ago
(26-May-2026)

11/12 (91.67%)

$30.06 (7.16%)

384

Buy Since 25-Nov-2015

$450

$63.09 (16.31%)

$275

1 months 20 days ago
(21-May-2026)

12/13 (92.31%)

$65.79 (17.12%)

278

Buy Since 11-Oct-2022

$450

$63.09 (16.31%)

$250

1 months 20 days ago
(21-May-2026)

11/12 (91.67%)

$65.79 (17.12%)

334

Buy Since 24-Aug-2023

$460

$73.09 (18.89%)

$425

1 months 20 days ago
(21-May-2026)

23/24 (95.83%)

$75.79 (19.73%)

394

Show more analysts

Please expand the browser size to see the chart

Which stock is Craig Hettenbach is most bullish on?

Potential upside of $24.88 has been obtained for VEEV (VEEVA SYSTEMS)

Which stock is Craig Hettenbach is most reserved on?

Potential downside of -$13.38 has been obtained for HIMS (HIMS HERS HEALTH)

What Year was the first public recommendation made by Craig Hettenbach?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?